Home  »  News   »  Why is Arrowhead Pharmaceuticals Inc. (ARWR) down ...

Why is Arrowhead Pharmaceuticals Inc. (ARWR) down -57.60% from the day 1 this year?

At the end of the latest market close, Arrowhead Pharmaceuticals Inc. (ARWR) was valued at $32.47. In that particular session, Stock kicked-off at the price of $32.43 while reaching the peak value of $34.795 and lowest value recorded on the day was $31.45. The stock current value is $34.56.Recently in News on June 7, 2022, Arrowhead Pharmaceuticals to Participate in Upcoming June 2022 Conferences. Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:. You can read further details here

Arrowhead Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $70.09 on 01/03/22, with the lowest value was $26.81 for the same time period, recorded on 06/14/22.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Arrowhead Pharmaceuticals Inc. (ARWR) full year performance was -57.60%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arrowhead Pharmaceuticals Inc. shares are logging -60.04% during the 52-week period from high price, and 28.91% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $26.81 and $86.48.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 877399 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Arrowhead Pharmaceuticals Inc. (ARWR) recorded performance in the market was -47.87%, having the revenues showcasing -26.03% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.63B, as it employees total of 329 workers.

Specialists analysis on Arrowhead Pharmaceuticals Inc. (ARWR)

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 40.85, with a change in the price was noted -14.43. In a similar fashion, Arrowhead Pharmaceuticals Inc. posted a movement of -29.45% for the period of last 100 days, recording 812,497 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARWR is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Trends and Technical analysis: Arrowhead Pharmaceuticals Inc. (ARWR)

Raw Stochastic average of Arrowhead Pharmaceuticals Inc. in the period of last 50 days is set at 38.01%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 86.88%. In the last 20 days, the company’s Stochastic %K was 75.93% and its Stochastic %D was recorded 77.91%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -47.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -47.68%, alongside a downfall of -57.60% for the period of the last 12 months. The shares increased approximately by 9.47% in the 7-day charts and went up by 1.05% in the period of the last 30 days. Common stock shares were lifted by -26.03% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts